Dapagliflozin improves endothelial integrity and hemodynamics in endotoxin treated mice through an apolipoprotein M dependent pathway
Carla Valenzuela Ripoll(Washington University in St. Louis), Ali Javaheri(Washington University in St. Louis), Ahmed Diab(Washington University in St. Louis), Zhen Guo(Washington University in St. Louis), Mualla Özcan(Washington University in St. Louis), Jess Nigro(Washington University in St. Louis), Kana N. Miyata(Washington University in St. Louis), Tripti Kumari(Washington University in St. Louis), Amanda Girardi(Washington University in St. Louis), Attila Kovács(Cardiovascular Research Center), Jaehyung Cho(Washington University in St. Louis), Carla J. Weinheimer(University of Washington), Christina Christoffersen(University of Copenhagen), Joel D. Schilling(Washington University in St. Louis), Jan Oscarsson(AstraZeneca (Netherlands)), Russell Esterline(AstraZeneca (United States)), Mikhail Kosiborod(AstraZeneca (Brazil)), Li He(Washington University in St. Louis)
Cited by 1
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2012|1.1k